Research Highlights

Researchers solve structure of protein linked to developmental problems

 

UT Southwestern researchers have solved the crystal structure of the yeast version of a protein that is crucial for human development.

Scientists find that it pays to count RNA

 

UT Southwestern Medical Center researchers have found that a small number of mutated RNA molecules can have major consequences on neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

How visceral fat leads to excess glucose production

 

Researchers at UT Southwestern Medical Center have demonstrated a pathway by which abdominal fat, in particular fat surrounding the internal organs, may lead to type 2 diabetes.

Joachim Herz Lab: Alzheimer’s risk

 

Researchers at the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center have compiled a review outlining how a specific form of protein increases the risk of developing Alzheimer’s disease.

Ege Kavalali Lab: Neural messaging

 

A molecule that helps neurons communicate also controls how quickly brain cells reform neurotransmitter-storing packets needed to continue messaging with other cells, according to a new study from researchers at the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center.

Advance in synthetic chemistry should aid drug development

 

Researchers at UT Southwestern Medical Center and collaborators report a significant advance in the synthesis of nitrogen-containing chemical compounds, which represent a majority of chemicals.

Research Highlight: Scientists pinpoint molecule that may strengthen body’s immune response

 

Researchers have identified a molecule in the skin that could strengthen the body’s immune response by repairing the thymus.

Research Highlight: Targeting molecules that replenish brain cells

 

Researchers at the Peter O’Donnell Jr. Brain Institute have identified a set of molecules that can be manipulated to promote the regeneration of neural stem cells crucial for learning and memory.

PIAS1 may offer new targets for blood cancer therapies

 

Researchers with the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been able to characterize interactions inside cells that they hope could lead to targeted treatments for lymphomas and other blood cancers.